Fuzeon Related Clinical Trials
Cohort Study for Patients Using Fuzeon (Enfuvirtide) [Active, not recruiting]
WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV. [Completed]
ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression. [Terminated]
AMICI Study: A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients. [Active, not recruiting]
Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance [Active, not recruiting]
Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection [Completed]
BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection [Completed]
BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. [Completed]
QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection [Completed]
A Study to Evaluate the Safety and Efficacy of Adding Fuzeon (Enfuvirtide) to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience [Completed]
A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients [Completed]
Evaluating the Effect of Switching ENfuvirtide to RALtegravir in HIV Infected Subjects [Active, not recruiting]
INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure. [Recruiting]
Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children [Completed]
HIV Maintenance Therapy With T-20 During HAART Interruption [Completed]
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load [Active, not recruiting]
Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules [Recruiting]
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [Completed]
T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs [Completed]
Fuzeon Viral Decay Pilot Study [Active, not recruiting]
Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration [Recruiting]
Effect of an Enfuvirtide-Based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults [Suspended]
Intensification With Enfuvirtide in Naive HIV-Infected Patients [Recruiting]
Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy [Completed]
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents [Completed]
A Study of T-20 in HIV-Positive Adults [Completed]
Raltegravir Substitution for Enfuvirtide in Patients Suffering From Injection Site Reactions (ISRs): The Raleve Pilot Study
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects. [Recruiting]
T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs [Completed]
Raltegravir Substitution for Enfuvirtide in Patients Suffering From Injection Site Reactions (ISRs): The Raleve Pilot Study [Recruiting]
Metabolic Effects of Enfuvirtide in Healthy Volunteers [Completed]
A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy. [Completed]
A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1 [Terminated]
Study of Enfuvirtide in HIV-Positive Subjects [Completed]
Adding New Drugs for HIV Infected Patients Failing Current Therapy [Completed]
Study of Valproic Acid to Treat HIV Infected Adults [Recruiting]
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) [Active, not recruiting]
Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients [Recruiting]
Optimizing Treatment for Treatment-Experienced, HIV-infected People [Recruiting]
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus [Active, not recruiting]
The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV [Completed]
TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial [Active, not recruiting]
Ventricular Pacing Site Selection (V-PASS) [Recruiting]
A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102 [Active, not recruiting]
Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir, Etravirine and MK-0518 in HIV Patients With Resistant Viruses [Active, not recruiting]
Clinical Trial of CNS-targeted HAART (CIT2) [Recruiting]
The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids [Recruiting]
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease [Completed]
Safety and Effectiveness of Addition of Maraviroc to ART Regimens in HIV-Infected Adults With Suboptimal CD4 T-Cell Count Recovery Despite Sustained Virologic Suppression [Recruiting]
|
